Potential interventions for HIV/AIDS wasting: An overview

被引：14

作者：

Abrams, DI ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco Gen Hosp, Posit Hlth Program, San Francisco, CA 94110 USA

来源：

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2000年 / 25卷

关键词：

Wasting syndrome; drug treatments; appetite stimulants; anabolics; thalidomide;

D O I：

10.1097/00126334-200010001-00012

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Although the HIV wasting syndrome has become a far less common manifestation of advanced disease since the introduction of highly active therapies, much has been learned about a number of potential therapeutic interventions. HIV wasting therapies are reviewed. The evaluation of some of these treatments for management of body habitus alterations associated with antiretroviral therapies may be appropriate.

引用

页码：S74 / S80

页数：7

共 46 条

[1]

ABRAMS D, 1997, MED MANAGEMENT AIDS, P143

[2]

Abrams DI, 1998, J PSYCHOACTIVE DRUGS, V30, P163

[3]

ARGURELL S, 1986, PHARMACOL REV, V38, P21

[4] DRONABINOL AS A TREATMENT FOR ANOREXIA ASSOCIATED WITH WEIGHT-LOSS IN PATIENTS WITH AIDS [J].